US Patent

US9855334 — Topical compositions comprising a corticosteroid

Formulation · Assigned to Promius Pharma LLC · Expires 2035-03-11 · 9y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects topical compositions that include a corticosteroid and a penetration-enhancing agent, without propylene glycol.

USPTO Abstract

Topical compositions comprising a corticosteroid and at least one penetration enhancing agent, wherein the composition is substantially free of propylene glycol.

Drugs covered by this patent

Temovate (CLOBETASOL PROPIONATE) · Fougera Pharms

Patent Metadata

Patent number: US9855334
Jurisdiction: US
Classification: Formulation
Expires: 2035-03-11
Drug substance claim: No
Drug product claim: Yes
Assignee: Promius Pharma LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.